Sort
34,240 grants matching “atherosclerosis”
The Nerve Terminal as the Site of Action for Type-2 Alkenes
$371,993Richard Michael Lopachin · Albert Einstein College Of Medicine · R01 · FY2014 · ES
NKT cells in lipoprotein Metabolism and atherosclerosis
$371,980Godfrey Shalom Getz · University Of Chicago · R01 · FY2008 · HL
Epidemiology of Cardiovascular Risk Factors in Women
$371,979University Of Pittsburgh At Pittsburgh · R01 · FY2004 · HL
Assembly and Trafficking of IK1 and SK3 in Endothelia
$371,950Daniel C Devor · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · HL
Epidemiology of Coronary Calcification in the Elderly
$371,901University Of Pittsburgh At Pittsburgh · R01 · FY2002 · HL
Role of PTEN in Vascular Lesion Formation
$371,900Mary Cm Weiser-Evans · University Of Colorado Denver · R01 · FY2011 · HL
Structures of Alpha 4 Integrins, Ligands and Antagonists
$371,869Timothy A Springer · Boston Children'S Hospital · P01 · FY2013 · HL
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR
$371,862Roy L Silverstein · Cleveland Clinic Lerner Com-Cwru · P50 · FY2008 · HL
Epidemiology of Vascular Inflammation &Atherosclerosis
$371,845University Of Vermont &St Agric College · R01 · FY2004 · HL
Roles of Plasminogen Activator Inhibitor-1 and Vitronectin in Failure of Coronary
$371,840William P Fay · University Of Missouri-Columbia · R01 · FY2011 · HL
JNK Suppression of Connexin43 Enhances Atrial Fibrillation in Aged Atria
$371,838Xun Ai · Loyola University Chicago · R01 · FY2015 · HL
CaMKII regulates key mechanisms of vascular response to injury in vivo
$371,837Isabella Maria Grumbach · University Of Iowa · R01 · FY2015 · HL
Mechanisms of Fibronectin Extra Domain A in Atherosclerosis
$371,837Anil Kumar Chauhan · University Of Iowa · R01 · FY2015 · HL
Fibronectin alternative splicing in thrombosis and inflammation
$371,837Anil Kumar Chauhan · University Of Iowa · R01 · FY2015 · HL
Nitroalkenes and Blood Pressure Regulation
$371,828Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2009 · HL
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin
$371,824Steven Shea · Columbia University Health Sciences · N01 · FY2020 · HL
Itch, proteases and protease-activated receptors
$371,817Ethan A Lerner · Massachusetts General Hospital · R01 · FY2014 · AR
Role of Plasminogen Activator Inhibitor-1 in Adipose Tissue Dysfunction and Atherosclerosis in Metabolic Syndrome
$371,803William P Fay · University Of Missouri-Columbia · R01 · FY2018 · HL
Embryonic origin and self-renewal of B-1a cells
$371,795Momoko Yoshimoto · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · AI
Genome-Wide Association for Loci Influencing CHD and Other Heart, Lung and Blood
$371,775Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · R01 · FY2007 · HL
Multidiscplinary Cardiovascular Research Training
$371,770University Of Michigan At Ann Arbor · T32 · FY2002 · HL
CHEMOKINE RECEPTORS BASED NANOAGENTS IMAGING ATHEROSCLEROSIS
$371,767Yongjian Liu · Washington University · R01 · FY2016 · HL
Interrogating function, regulation, and interactions in a clade of prevalent human gut microbes
$371,738Patrick Joseph Bradley · Ohio State University · R35 · FY2023 · GM
Iron Therapy in Renal Disease: Potential Toxicities
$371,656Richard A. Zager · Fred Hutchinson Cancer Research Center · R01 · FY2006 · DK
Regulation of CNS leukocyte extravasation
$371,644Joel S Pachter · University Of Connecticut Sch Of Med/Dnt · R01 · FY2020 · NS